We can also hypothesize that the high rate of overlap between TP53 and ATM aberrations in our cohort (23 patients) causes higher genome instability and deletes relatively better outcomes for MCL patients with del17 compared to those with mutTP53. The gene discussed is TP53; the disease is mantle cell lymphoma.